SECURITIES AND EXCHANGE COMMISSION
                              WASHINGTON, DC 20549

                                   FORM 12b-25

                                                Commission File Number 000-07405


                           NOTIFICATION OF LATE FILING


(Check One):  [_] Form  10-K [_] Form 11-K [_] Form 20-F [X] Form 10-Q
              [_] Form N-SAR

For Period Ended:                          May 31, 2004
                 ---------------------------------------------------------------

[_]    Transition Report on Form 10-K     [_]    Transition Report on Form 10-Q
[_]    Transition Report on Form 20-F     [_]    Transition Report on Form N-SAR
[_]    Transition Report on Form 11-K

For the Transition Period Ended:
                                ------------------------------------------------

     Read attached  instruction  sheet before  preparing  form.  Please print or
     type.

     Nothing in this form shall be  construed to imply that the  Commission  has
     verified any information contained herein.

     If the  notification  relates  to a portion of the  filing  checked  above,
     identify the item(s) to which the notification relates:


     ---------------------------------------------------------------------------

                                     PART I
                             REGISTRANT INFORMATION

Full name of registrant             Mediscience Technology Corp.
                       ---------------------------------------------------------


Former name if applicable             Cardiac Techniques Inc.
                         -------------------------------------------------------

                                        1235 Folkestone Way
- --------------------------------------------------------------------------------
Address of principal executive office (Street and number)

City, state and zip code          Cherry Hill, New Jersey 08034
                        --------------------------------------------------------


                                     PART II
                             RULE 12b-25(b) AND (c)

     If the subject  report could not be filed  without  unreasonable  effort or
expense  and  the  registrant  seeks  relief  pursuant  to Rule  12b-25(b),  the
following should be completed. (Check appropriate box.)

[X]       (a) The reasons  described  in  reasonable  detail in Part III of this
          form could not be eliminated without unreasonable effort or expense;

[X]       (b) The subject annual report,  semi-annual report,  transition report
          on Form 10-K,  20-F,  11-K or Form N-SAR,  or portion  thereof will be
          filed on or before the 15th calendar day following the  prescribed due
          date; or the subject  quarterly  report or  transition  report on Form
          10-Q, or portion thereof will be filed on or before the fifth calendar
          day following the prescribed due date; and






[_]       (c) The  accountant's  statement  or other  exhibit  required  by Rule
          12b-25(c) has been attached if applicable.

                                    PART III
                                    NARRATIVE

     State below in  reasonable  detail the reasons why Form 10-K,  11-K,  20-F,
10-Q,  N-SAR or the transition  report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)

     The Registrant was unable to file the Form 10-QSB for the quarter ended May
31,  2004 (the  "Report")  without  unreasonable  effort or  expense  due to the
related delays in gathering  information for inclusion in the Report  associated
therewith.

                                     PART IV
                                OTHER INFORMATION

     (1) Name and  telephone  number  of  person  to  contact  in regard to this
notification

Peter Katevatis                     (856)                         428-7952
- --------------------------------------------------------------------------------
    (Name)                       (Area Code)                  (Telephone number)

     (2) Have all other periodic  reports  required under Section 13 or 15(d) of
the Securities  Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940  during the  preceding  12 months or for such  shorter  period  that the
registrant was required to file such report(s) been filed?  If the answer is no,
identify report(s).
                                                                  [X] Yes [_] No


     (3) Is it anticipated that any significant  change in results of operations
from the corresponding  period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
                                                                  [_] Yes [X] No

     If so: attach an explanation of the anticipated  change,  both  narratively
and  quantitatively,  and, if  appropriate,  state the reasons why a  reasonable
estimate of the results cannot be made.

                          Mediscience Technology Corp.
- --------------------------------------------------------------------------------
                  (Name of Registrant as Specified in Charter)

Has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.

Date     July 15, 2004                          /s/ Peter Katevatis
     -----------------                          --------------------------------
                                                Name:  Peter Katevatis
                                                Title: Chairman of the Board and
                                                       Chief Executive Officer

     Instruction.  The  form  may  be  signed  by an  executive  officer  of the
registrant or by any other duly authorized representative. The name and title of
the person signing the form shall be typed or printed beneath the signature.  If
the  statement  is  signed  on  behalf  of  the   registrant  by  an  authorized
representative   (other   than   an   executive   officer),   evidence   of  the
representative's  authority to sign on behalf of the  registrant  shall be filed
with the form.

                                    ATTENTION

Intentional  misstatements  or omissions  of fact  constitute  Federal  criminal
violations. (See 18 U.S.C. 1001).